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Abstract 
This study examined the effects of a smoking cessation program using vouchers 
as reinforcers with individuals with traumatic brain injury and a history of substance 
abuse.  The intervention was conducted at a residential facility that houses individuals 
with Traumatic Brain Injury (TBI).  Vouchers were delivered contingent on reductions of 
carbon monoxide (CO) samples of 5 ppm or less across a shaping phase, and an 
abstinence induction phase.  A standard pay phase was added at the end of the study to 
examine the effects of a standardized reinforcement scale with the abstinence criterion set 
at 8 ppm or less. Reductions in CO were not robust in the shaping and abstinence 
induction phase.  The standard pay schedule showed some improvements in CO levels 
with less variability for two of the three participants.     
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Introduction 
    According to the CDC smoking is the leading cause of death in the U.S.  From 
1998 to 2008 smoking declined to 20.6%, which was a 3.5% reduction from the previous 
years (Center for Disease Control, 2009).  Men in the United States have a smoking 
prevalence rate of 23.1% and women 18.3%.  Smoking carries with it a number of health 
risks which include various types of cancer.  It has been linked to kidney, laryngeal, lung, 
cervical, bladder, esophageal, pancreatic, and oral cancer (CDC, 2009).  Along with these 
risks include heart disease, cerebrovascular atherosclerosis, and a number of respiratory 
diseases (CDC, 2009).  Between 2000 and 2004, smoking resulted in 269,655 deaths 
among men and 173,940 deaths among women in the United States (Adhikarri, Khende, 
Malarcher, Pechacek, &Vong, 2009).  Despite these risks, between 2007 and 2008 there 
was a modest increase in smoking which stunted the nationwide Healthy People 2010 
objective of reducing the prevalence of cigarette smoking to < 12% among adults (CDC, 
2009).  And although adolescent smoking use declined from 1997 to 2003, the prevalence 
rate remained stable with 20% of high school students still smoking cigarettes.   
     With the many health risks associated with smoking, a number of cessation 
treatments have been tested showing positive effects with short and long term abstinence 
among adults (Khazall, Cornux, Bilancioni, & Zullino, 2006; Kornitzer, Boutsen, 
Dramaix, Thijs, & Gustavsson, 1995; Oncken et al., 2006; Schneider et al., 1995; Schnoll 
et al., 2010; Stapleton et al., 1995).   Such treatments have included medications such as 
nicotine replacement therapies (NRT) that incorporate the use of lozenges, nicotine 
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inhalers, nicotine nasal sprays, nicotine patches or nicotine gum to help reduce smoking 
(Aveyard, Johnson, Fillingham, Parsons, & Murphy, 2008; Cooney et al., 2009; 
Schneider et al., 1995; Shiffman et al., 2002; Sutherland & Stapleton, 1992).  Some NRT 
products are designed to show an immediate effect by impacting the amount of craving 
an individual encounters.  While others are designed to release a continuous supply of 
nicotine throughout a 24 hour period and provide a more gradual effect that has led to 
abstinence being verified at one year follow up (Shiffman et al., 2002).   
     Additional medications have included antidepressants such as bupropion and 
nortriptyline, which have shown long term abstinence (Fossati et al., 2007). Varenicline, 
a nicotine blocker, has shown to be effective with higher continuous abstinent rates in 
comparison to a bupropion and placebo group at 52 week follow-up (Jorensby et al., 
2006).   Topiramate, an anticonvulsant medication, has shown more gender specific 
effects in men with men four times more likely to quit when treated with Topiramate than 
men in the placebo group (Anthenelli, Blom, McElroy, & Keck, 2008).   
    Some other treatments have included combinations of NRT with components 
such as practitioner’s advice and educational material, and have demonstrated positive 
effects for abstinence (Russell, Merriman, Stapleton, & Taylor, 1983).  This is further 
supported by later studies that have implemented combination approaches and also 
demonstrated positive effects (Buchkremer, Bents, Horstmann, Opitz, & Tolle, 1989; 
Puska et al., 1995; Russell, Merriman, Stapleton, & Taylor, 1983).  By themselves, 
certain NRTs may be more effective in conjunction with behavioral support that includes 
counseling and advice from a nurse practitioner (Leischow, Ranger-Moore, Muramoto, & 
Mathews, 2004).  Buchkremer et al. (1989) implemented a combination approach with a 
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behavioral component that included a deposit contract designed to assure attendance in 
small group training sessions and showed efficacy with reductions in smoking. 
     A number of studies have included contingency management programs using 
money and have yielded positive results as well.  Rand, Stitzer, Bigelow, and Mead 
(1989) implemented a combination approach that included contingency management in 
conjunction with frequent monitoring in a between-group design at a worksite delivering 
payment contingent on lower levels of CO.  This resulted in a delay in relapse that was 
significantly different than the placebo and the noncontingent group (Rand et al., 1989).  
In another study Stitzer, Rand, Bigelow and Mead (1986) introduced a contingency 
management intervention that utilized a sliding scale for money earned contingent on 
reductions in CO level.  In the final two weeks of the study participants had the 
opportunity to earn $12 a day if they were completely abstinent and provided breath 
samples three times a day.  Results demonstrated that most of the participants were 
willing to attempt abstinence during the last two weeks and that 80.5% were breathing < 
8 ppm in CO demonstrating a significant reduction from pre-study readings (Stitzer et al., 
1986).  In a more recent study done by Reynolds, Dallery, Schroff, Patak, and Leraas 
(2008), researchers monitored four adolescents for smoking abstinence and found that all 
participants achieved prolonged abstinence when money was delivered contingent on CO 
levels < 5 ppm. 
     In other instances vouchers have been shown to be effective.  Dunn, Sigmon, 
Thomas, Heil, and Higgins (2008) found a voucher based contingency management 
program to be effective in curbing smoking with methadone-maintained individuals.  
They also found a greater percentage of abstinent samples were provided with the 
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contingent group than the noncontingent control group (Dunn et al., 2008).  Other novel 
approaches have included the use of drawings as well as the use of deposit contracts.  
Alessi, Petry, and Urso (2008) implemented a contingency management intervention with 
residents that involved the earning of draws in a raffle drawing with each negative CO 
reading.  Results showed decreases in cigarettes smoked and reduced levels in CO with 
residents entering a substance abuse program (Alessi et al., 2008).  Dallery, Meredith, 
and Glenn (2008) used deposit contracts that were demonstrated to be feasible in 
delivering reinforcement for abstinence.   
     Approximately 200,000 individuals with mental health illness die annually of 
tobacco related disease.  For people with mental illness and a history of substance abuse, 
nicotine addiction  is generally much more severe than in the general public (Schroeder & 
Morris, 2010).  Additionally, 77%-93% of individuals in substance abuse clinics use 
tobacco products (Schroeder & Morris, 2010).  Individuals with mental illness/substance 
use disorder also have a tendency to die 25 years earlier than the general population as a 
result of smoking and previous existing conditions (Schroeder & Morris, 2010).  In 
addition to the health consequences, smoking places a financial toll on individuals with 
mental illness and substance abuse problems by impacting the way money is managed.  
Approximately 27% spend their money on smoking (Schroeder & Morris, 2010).  Part of 
becoming more independent involves having the ability to manage money wisely.  
Without money management skills, integration back into the community becomes more 
difficult.   
     With populations with mental illness/substance abuse, the success of smoking 
cessation may be predicted by symptoms of comorbid diagnosis of depression.  Niaura et 
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al. (2001) in one study examined pre-treatment symptoms of depression and the time to 
relapse to see if symptoms could predict the time to relapse.  Researchers concluded that 
minimal symptoms of depression, described as pre-treatment mood, were enough to 
predict the survival of quit attempts.  But life time history of depression did not (Niaura 
et al., 2001).  Treatments for individuals with mental illness have included many of the 
FDA approved medications that are typically used by the general population (Schroeder 
& Morris, 2010).  Because individuals with mental illness or substance dependence often 
have more severe nicotine addictions, individuals also require more intensive treatment 
that may include higher doses and longer durations of treatment, and potentially more 
combinations of interventions that are included in a highly individualized treatment plan 
(Schroeder & Morris, 2010).  Despite the impact smoking has on these individuals, 
tobacco control with this population has been insufficient and requires further research 
(Schroeder & Morris, 2010). 
     Furthermore most research on smoking cessation has focused on interventions 
with typically developing adults.  Much of the research on smoking also focuses on 
surveys determining variables predicating smoking prevalence rather than interventions 
(Fagan, Brook, Rubenstone, & Zhang, 2005; Shiffman, Brockwell, Pillitteri, & Gitchell, 
2008; Slomkowski, Rende, Novak, Lloyd-Richardson, & Niaura, 2004).  No known 
research has focused on adult smokers with traumatic brain injury (TBI) who may also be 
dually diagnosed with psychiatric illness and a history of substance abuse.  Further 
research for this population is needed considering that many individuals with comorbid 
substance use disorder are also addicted to nicotine.  Individuals with TBI often have 
other diagnoses including Post Traumatic Stress Disorder (PTSD) where symptoms might 
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include intense fear and anxiety, and insomnia (Lew et al., 2008; Parcell et al., 2006).  In 
one study insomnia was reported in 80% of participants with TBI (Parcell et al., 2006).  
Among individuals with TBI, substance use disorder is found to be more severe and 
many also experience higher rates of depression, and anxiety with increases in suicide 
attempts (Felde, Westermeyer, & Thuras, 2006).  Many prescribed medications for 
smoking cessation have side-effects that may resemble symptoms associated with 
comorbidity.  For example bupropion, which is generally prescribed as an antidepressant 
and has been approved for use in smoking cessation, has been known to cause reactions 
such as sleeplessness, panic attacks, depression, irritability, and seizures which are 
common among individuals with  TBI (“Side effects”, 2010).  Nortriptyline is another 
common antidepressant medication that shares some of the same side-effects that include 
changes in mood, suicidal ideations, trouble sleeping with the addition of heart pounding 
(“Side effects”, 2010).  These types of effects can lead to greater difficulties with 
independence and general well-being and also impact the outcome of any treatment.  In 
cases in which prescribed medications can not be used, alternatives could include 
nicotine replacement therapies such as nicotine gum or nicotine patches which have been 
demonstrated to be effective and even more effective as combination treatments (Puska et 
al., 1995).  However, these treatments also have side-effects such as skin irritation, mouth 
and throat soreness, nausea, vomiting, and coughing.  More serious side-effects may also 
include heart palpitations and chest pains along with insomnia (Mills, Lockhart, Wilson, 
& Ebbert, 2010).  Even if side-effects were controlled for individuals with TBI, the use of 
nicotine replacement therapies may be contraindicated if individuals have preexisting 
medical conditions (“Side-effects”, 2010).   
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     Other options are needed for individuals with TBI.  Contingency management 
programs have been effective in reducing CO levels in individuals who smoke without 
the potential harm associated with medications.  As described earlier, many studies have 
examined the use of vouchers, lottery tickets, and raffle drawings and in many cases these 
have been shown to be effective for smoking cessation (Alessi et al., 2008; Dunn et al., 
2008; Neese, 2009).  This study extends previous research on smoking cessation studies 
that have used vouchers as reinforcers and also incorporates other behavioral components 
that have been used to decrease smoking such as frequent monitoring, self-monitoring, 
and vouchers.  The main purpose of this study was to examine the efficacy of using 
vouchers in a smoking cessation intervention with individuals with TBI and a history of 
smoking.   
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Method 
Participants 
     Three participants, 1 female and 2 male with traumatic brain injury (TBI) and 
with a history of at least 1 year of smoking participated in the study.   Amanda was a 36-
year-old Caucasian female who was a left leg amputee which was the result of an 
automobile accident.  Amanda was diagnosed with bipolar disorder, chronic anemia, and 
TBI.  Her past diagnoses have included substance use disorder.  Amanda was undergoing 
treatment for pain that she was experiencing in her phantom limb and had difficulty 
walking with her prosthetic.  She spent most of her time ambulating using her wheel 
chair. Amanda reportedly had smoked for about 20 years starting at the age of 15 and had 
attempted quitting at least once.  In the past Amanda had used the patch and Chantix- a 
prescribed medication that blocks the nicotine receptors of neurons.  Amanda reportedly 
smoked approximately 22 cigarettes a day.   Harry was a 45-year-old Asian American 
male diagnosed with a TBI, substance use disorder and type II diabetes. His TBI was 
sustained from an automobile accident.  As a result he had residual deficits to his short 
term memory, concentration, and dysphasia.   His drug use had included alcohol, opiates, 
cocaine and marijuana.  Harry reportedly had never attempted quitting smoking and 
never used any nicotine replacement therapy.  Harry reportedly smoked about 10 
cigarettes a day and had smoked for 27 years.  Mark was a 34-year-old Caucasian male 
who sustained a TBI after falling from a wall while on active duty.  His past diagnoses 
had included bipolar disorder and substance use disorder.  His drug use included opioids, 
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cocaine, marijuana, alcohol, and heroin.  In the past Mark had made quit attempts at least 
4 times and had used the patch as part of his nicotine replacement therapy.  Mark 
reportedly smoked 16-20 cigarettes a day and had smoked for 22 years.  The residential 
facility, in which all three participants resided, assessed functioning level using the 
Rehabilitations Institute of Chicago Functional Assessment Scale (RIC-FAS).  Based off 
of the RIC-FAS, participants had a minimum of mild to moderate impairment and a 
rating of 4-5 on the memory scale. Individuals who have a rating of 4 require minimal 
prompting, and they recognize and remember 75-90% of the time.  Participants who 
score a 5 require prompting only under stressful conditions, but no more than 10% of the 
time.  Participants also had a minimum baseline CO level between 10 and 15 parts per 
million (ppm) and were not currently part of a smoking cessation program.   
Setting   
     The setting was at a residential facility that housed 20 residents with TBI.  In 
the residential facility there were approximately 200 employees with 8-10 care takers 
assigned to each shift.  Many of the residents were part of a work hardening program in 
which they worked at the residential housing facility earning money doing odd jobs 
which included grounds keeping, cleaning, and stuffing brochures.  As a part of their 
program residents undergo inpatient treatment which includes cognitive therapy, 
counseling, physical training, and behavioral services.  Behavioral services are 
implemented as part of a comprehensive program designed to reduce problem behaviors 
that may include verbal outbursts, elopement, drug seeking, and physical aggression.  
Additionally behavioral services are provided to facilitate the acquisition of skills for 
independence with the eventual goal for residents to be able to live on their own.  Two of 
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the participants Amanda and Mark lived in apartments with roommates on the residential 
campus.  Harry lived in a group home with one other client not participating in the study.   
Interview 
     Prior to the start of intervention, each participant underwent a brief counseling 
session provided by the board certified behavior analyst at the facility via a power point 
presentation format that covered setting a quit date, tips on gaining support from friends 
and family, planning for challenges, and removing triggers to smoking in the 
environment using the Clearing the Air: Quit Smoking Today booklet (attached to 
appendices).  At the conclusion of the counseling session, motivation for quitting was 
assessed using the University of Rhode Island Change Assessment Long Form (URICA) 
(Appendix 1) (University of Rhode Island Cancer Prevention Research [URICA], 1991).  
The addition of a counseling session with the booklet and the assessment for motivation 
was based off of an earlier study by Glenn and Dallery (2007).  Demographic information 
was gathered through a review of the participants’ file.  Information that was gathered  
included gender, age, current diagnoses, race, history of smoking, age of first cigarette, 
and current medical conditions.   
     Withdrawal, craving, and nicotine dependence can be important factors for 
long term abstinence and relapse and were assessed using different assessment scales.  
Nicotine dependence was assessed during baseline using the Fagerstrom Test for 
Nicotine Dependence (Appendix 2) to assure dependence at the start of the study 
(Fagerstrom, Heatherton, & Kozlowski, 1991).Withdrawal severity is a predictor of 
relapse and was tracked throughout the study.  Withdrawal was assessed at the beginning 
and end of baseline conditions, at the end of the shaping phase, at the end of the 
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abstinence induction phase, and at the end of the standard pay phases using the 
Minnesota Withdrawal Scale Revised (MWSR) (Appendix 3) (Hughes & Hatsukami, 
2008).  Craving severity is also important for predicting long term abstinence and was 
included on the scale as part of the total score (MWSR).   
CO Monitoring 
     Carbon monoxide (CO) was measured using the Bedfont Micro-Smokerlyzer.  
The CO monitor was tested for validity and reliability by having a non-participant non-
smoker exhale into the monitor twice before the start of baseline and once per week 
throughout the study.  The two readings for the non-smoker were compared to each other 
to determine reliability.  The two readings for the smoker were also compared to each 
other to determine the reliability of the readings.  A comparison of readings between 
smoker and non-smoker was conducted to determine validity. If the smoker’s reading 
was higher than the non-smoker’s reading for both exhalations then this would indicate 
instrument validity.   To get an accurate reading the participant inhaled and held their 
breath as the device counted down from 15 s.  During the last three seconds the device 
beeped briefly for the first two seconds and beeped one continuous tone for the third 
second.  At the end of the beep the participant placed their mouth onto the cardboard 
mouth piece attached to a plastic D-piece on the front of the CO monitor and exhaled into 
the device continuously.  After the participant completely exhaled into the device, a 
reading was delivered in parts per million (ppm) on the display located on the front of the 
monitor.  
     Participants provided 4 CO readings each day separated by at least 5 hrs and 
not to exceed 8 hrs in between readings (Reynolds et al., 2008).  This requirement was 
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included because the half-life of CO is 4 to 5 hrs.  After 5 hrs trace amounts of CO can be 
detected at up to 8 hrs.  One CO sample was given in the morning between 8 am and 9 
am.  The second CO sample was given in the afternoon between 12 pm and 2 pm.  The 
third CO sample was taken early evening between 5 pm and 7 pm.  And the last CO 
sample was taken prior to each participant going to bed.  For participant 1 her last sample 
was taken at 9 pm.  For participant 2 and 3 their samples were taken between 10 pm and 
11 pm before they went to bed.  
Staff Training 
     A task-analysis for the CO monitor is located in Appendix 4.  Prior to the 
study, staff members and research assistants were trained to use the CO monitor by 
practicing on themselves with the trainer.  The use of the CO monitor was modeled by 
the trainer before assistants and staff members practiced on themselves.   Staff members 
and research assistants were graded on the completion of the steps in the task analysis 
and required to retest until 100% had been achieved.  Research assistants and staff 
members were trained on data documentation which included the CO level, the amount of 
money a participant earned per CO reading and the serial number of each of the vouchers.  
Assessment tools (i.e. the URICA, MWSR, and Fagerstrom) were administered by the 
researcher and the BCBA at the facility.  Research assistants and staff members all scored 
100% after training.   
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Experimental Design 
     The study used a multiple baseline design across participants with an 
ABCADA format, which included a baseline (A), shaping condition with an increasing 
pay scale (B), abstinence induction condition (C) and a standard pay scale (D).  
Baseline 
  Throughout all phases of the study, staff members were only allowed to smoke 
in areas out of sight of the participants. Incidentally a company wide non-smoking policy 
was also put into place for all employees.  In baseline, participants in the study were 
allowed to continue smoking as they normally would.  There were no consequences 
delivered for smoking cigarettes.  CO levels were taken 4 times a day as described 
previously.   
Shaping 
     Vouchers had values assigned to them with the amount displayed on the front.  
To help reduce the risk of participants falsifying the values of the vouchers, the vouchers 
each had their own serial number.  For their first sample participants were given a 
voucher for a CO sample lower than their baseline mean.  For each additional sample a 
voucher was delivered if their CO sample was less than their previous sample.   
Participants’ initial CO level below baseline mean resulted in a voucher worth $2.00.  
Each successive reduction resulted in a .25 increase until CO levels stabilized at or below 
5 ppm at which time vouchers were no longer delivered for successive reductions 
(Reynolds et al., 2008).  For example the initial CO sample was $2.00.  The second CO 
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sample was $2.25.  The third CO sample was $2.50.  The fourth sample was $2.75.  This 
continued until the participant reached $5.75.  Increases in CO levels before reaching 5 
ppm, resulted in the voucher amount resetting to the initial amount of $2.00 (Dunn et al., 
2008; Glenn & Dallery, 2007; Reynolds et al., 2008).   The participants had the potential 
of earning up to $62.00 during the shaping procedure.  After an increase in CO, 
participants had the opportunity to reinstate the voucher amount with 3 negative CO 
readings (less than or equal to 5ppm) (Dunn et al., 2008; Reynolds et al., 2008).    
     Daily goals for reductions were based off of each participants’ average 
baseline CO level and were established across four days so that on the fourth day the CO 
level would be less than or equal to 5 ppm.  Goals for each day were established by 
reducing the baseline mean for each participant by 25% across four days.   Bonuses were 
assigned for achieving the predetermined goals within the specified time period.  For 
achieving the first goal the participant was able to earn $5.  This amount increased in 
increments of $5 with the accomplishment of each goal across the 4 days.  For this 
portion of the reinforcement contingency the participant had the potential of earning up to 
$50 vouchers for reaching all of the goals. Participants were not able to earn bonuses 
more than once.  For example upon earning a bonus, the participant could not provide a 
sample with a higher CO level then reduce the CO level again to earn the same bonus.  
The purpose of this reinforcement schedule was to increase the likelihood of reductions 
in CO occurring within the specified period of time.  Without this contingency, it was 
possible that participants could still earn vouchers in reductions in CO, but still not 
achieve any of the predetermined goals.   
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     Additionally participants were provided feedback on their progress by the 
research assistants and staff members administering the CO monitor.  Feedback included 
the provision of praise and congratulatory remarks if the participant reduced their CO 
levels or corrective feedback if they did not reduce their CO levels. After the delivery of 
a CO sample, participants were shown the CO reading and reminded of the criteria they 
needed to meet in order to receive the bonus vouchers.  Graphical feedback including 
current performance, total earnings, and total available earnings was delivered twice a 
day, once prior to the morning sample and once prior to the early evening sample.      
Abstinence Induction  
     At the conclusion of the shaping phase the abstinence induction phase began.  
Participants were given vouchers for providing a CO sample equal to or less than 5 ppm.  
Voucher values during this phase equaled the last amount they were earning during the 
shaping phase minus the bonus amounts.  The induction phase lasted 10 days.  This phase 
was based upon an earlier study by Dallery et al. (2008).  Because the most a participant 
could earn per reduction in CO sample during the shaping phase was $5.75, during the 
abstinence induction phase participants had the opportunity to earn up to $230.00 total if 
they ended the shaping phase at $5.75.   During the abstinence induction phase graphical 
feedback was faded to once a day in the morning 
Return to Baseline 
     As an evaluation of maintenance effects, following the abstinence induction 
phase participants returned to the baseline condition.  During this time participants were 
allowed to continue smoking as they normally would.  There were no consequences 
delivered for smoking cigarettes.    
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Standard Pay Schedule   
     As a result of a lack of intervention success and maintenance, the standard pay 
schedule condition was added to evaluate the differences between an increasing scale of 
reinforcement (shaping) and standard pay scale (abstinence induction and standard pay 
condition with higher voucher value).  This condition was similar to the abstinence 
induction condition in that a flat amount was delivered contingent on the participant 
achieving abstinence criterion.  Additionally the abstinence criterion was changed to 8 
ppm or less. During the standard pay condition the graphical feedback was given once a 
day in the morning or early afternoon 
Inter-Observer Agreement 
     A task analysis on the use of the CO monitor was used.  Research assistants 
collected inter- observer agreement (IOA) for 42% of the sessions for each participant 
across all conditions to monitor the appropriate use of the CO monitor and the measure of 
CO.  Inter-observer agreement was calculated by dividing the number of agreements by 
10 (total number of steps in the task analysis).  An agreement was defined as the step 
from the task analysis in which two observers recorded the step being followed correctly.  
A disagreement was the extent to which both observers recorded differences in the step 
being followed (i.e., one observer scored that the step was completed correctly while the 
other observer recorded that the step was not completed correctly).  The level of CO on 
the monitor was recorded by two observers. Both observers needed to record the exact 
number in ppm to be in agreement.  IOA was 100% for the observed CO measure and 
100% for the use of the CO monitor. 
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Results 
     Across all three participants high variability was identified during baseline and 
throughout the intervention (Fig 1).  Upon the introduction of the shaping condition for 
Amanda there was a gradual reduction in her CO levels.  For Amanda, a decreasing trend 
occurred beginning from the shaping condition and continuing to the first 6 samples of 
the abstinence induction phase where sharp spikes in her CO level began to appear with 
levels of 22 ppm, 20 ppm, and 18 ppm.    With a return to baseline, for Amanda CO 
variability was less than the shaping and abstinence induction phase.  Her performance 
continued along an increasing trend and response variability returned to higher levels as 
the standard pay condition was introduced. 
     During the introduction of the shaping condition for Harry a sharp decline in 
his CO level was identified while Mark continued to show stability during his baseline 
CO levels. Harry’s CO levels began to lose stability once the abstinence induction 
condition was introduced.  There was also an increasing trend with high variability 
around level of responding beginning to approximate his baseline variability, with 
increases appearing more gradual than Mark’s performance during the abstinence 
induction condition. When Harry returned to baseline his CO levels continued to show 
similar levels to the abstinence induction phase.   For Harry the standard pay schedule 
demonstrated reductions in CO levels but began to increase with the return to baseline.   
     Upon the introduction of the shaping condition for Mark his CO levels 
gradually reduced .  Mark’s CO reductions continued until the beginning of the 
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abstinence induction condition in which increases in CO levels occurred for all three 
participants.  With the introduction of the abstinence induction condition Mark’s first CO 
sample immediately increased to a level consistent with his baseline samples.  This 
continued with less variability than his baseline samples with his highest reading being 
17 ppm in comparison to his highest reading during baseline being 22 ppm. Mark’s return 
to baseline resulted in a reduction in variability which continued into the standard pay 
condition.      
     Scores from the URICA (Table 2) for Mark indicate d his readiness to change 
fell between the contemplation and the action stages with readiness to change being 
highest with the action stage with a score of 32.  His score for the contemplation stage 
was 31.  Lowest scores were 17 for the pre-contemplation stage and 27 for the 
maintenance stage.  Amanda’s highest score was in the contemplation stage with 33.  Her 
next highest was in the maintenance stage with 26 followed with action stage with 25 and 
pre-contemplation with 11.  Harry’s scores, similar to Amanda, were highest in the 
contemplation stage with 31 which were followed by 27, 25, and 7 for the maintenance, 
action, and pre-contemplation stages.    Participants together earned a total of $346 in the 
study. Participants were all able to earn their $50 bonuses.  Amanda earned a total of 
$103.75.  Harry earned a total of $153.00.  And Mark earned $89.25 (See Table 3 for 
details on earnings during each phase). 
     Craving scores for Mark started off at 4 during baseline then reduced to 2 in 
the remaining conditions.  For Amanda, her craving score started off at 4 during baseline 
then reduced to 3 during the shaping phase.  Her scores further reduced to 2 during the 
abstinence induction phase and the baseline phase.  During the standard pay phase, her 
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score returned to 3 and stayed there during the return to baseline.  Harry’s craving score 
started off at 2 during the initial baseline then increased to 3 during the shaping phase.  
His highest score of 4 occurred during the abstinence induction condition after which it 
reduced to 3 during baseline and the standard pay phases.  During baseline his scores 
returned to 2 and remained there.   
     Items 1-9 were summed for withdrawal scores for all participants.  For Mark 
his score was 8 during baseline, which increased to 11 during the shaping phase and 
reduced to 9 during the abstinence induction phase.  During his second baseline his score 
increased to 16 then returned to 9 in his standard pay phase.  Amanda’s initial baseline 
score was 20.  Her scores reduced slightly to 16 during the shaping phase then returned to 
20 during the abstinence induction phase.   Following the abstinence induction phase was 
the second baseline in which her score reduced to 12.  During the standard pay condition 
her withdrawal score increased to 22 and rose even further to 25 during the final baseline 
phase.  Harry’s score during the initial baseline was 20.  His score reduced to 8 during the 
shaping phase then rose again to 16 during the abstinence induction phase.  A return to 
baseline showed a slight reduction in withdrawal with a score of 15 and a further 
reduction during the standard pay phase with a score of 12.  During his final baseline his 
withdrawal score rose back to 17.   Fagerstrom scores for Mark, Amanda, and Harry were 
3, 3, and 1. 
     Out of a total of 182 samples, Mark was able to provide 92% of the samples 
missing 13.  Out of a possible 174 samples, Amanda provided 94% of the samples 
missing 9.  Out of 180 total possible samples, Harry provided samples for 93% of them, 
missing 11.   
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Discussion 
     The purpose of the study was to extend research on smoking cessation 
programs using voucher reinforcers for achieving reductions in smoking.  Research 
typically included a shaping condition and an abstinence induction condition.  Schedules 
of reinforcements usually involved the delivery of vouchers along an increasing scale or a 
standard pay scale.  In some studies the standard pay scale was used in the shaping phase 
and in other studies the standard pay scale was used in the abstinence induction phase.  
This study used an increasing scale as part of the shaping phase and a flat rate scale as 
part of the abstinence induction phase.  Research using this methodology has focused on 
typical adults and adolescents that smoke. This study focused on a population of TBI 
clients at a residential facility.  The participants in this study all reached 5 ppm or less, 
however, overall never consistently maintained the abstinence criteria. Amanda and Mark 
both showed CO reductions during the shaping phase.  Looking at their last phases and 
comparing it with their initial baseline phases further reductions were observed.  For 
Mark a clear reduction in variability was identified in his last phase only after the criteria 
for abstinence changed to 8 ppm.  Amanda’s lower levels however appeared to be more 
of a continuation of reductions observed in her second baseline indicating the need for 
better experimental control.  Harry also showed reductions once the criteria changed to 8 
ppm.  CO levels for him during the standard pay phase began to approximate his shaping 
phase. The standard pay phase for Harry should have been continued for a longer period 
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of time.  Doing so would have given a better understanding of whether or not a reinforcer 
contingency could produce reductions similar to Harry’s shaping phase.   
     Individuals with TBI, as a result of experiencing their injury, often exhibit a 
number of complications related to psychiatric disorder.  With depression, for example, 
many experience sadness, irritability, fatigue, loss of sleep, psychomotor retardation, 
difficulty concentrating and memory dysfunction (Seel et al., 2003).  It is a possibility 
that some of these symptoms could have altered the effectiveness of the smoking 
cessation intervention.   Cognitive impairment is often times an outcome to TBI which 
may impact a person’s overall functioning (Schretlen & Shapiro, 2003).  TBI patients 
often experience difficulty multitasking and so experience cognitive overwhelming which 
has been described to cause irritability ranging from mild to severe (Lux, 2007).   Mood 
disturbances are common with TBI clients.  Amanda, for example, who was currently 
diagnosed with bipolar disorder, for the first half of the study engaged in a number of 
verbal outbursts almost daily.  Mark in the past was also diagnosed with bipolar disorder 
and during the study exhibited some mild outbursts.  Whether or not this was a residual 
symptom of his previous diagnoses is not known.  Response efforts for cognitive tasks 
are high with individuals with TBI and so may have impacted participants’ abilities to 
manage their smoking by following the tips presented during the initial counseling 
session and performance feedbacks.  Moreover impairments in executive functioning 
which involve planning, monitoring, and self-correction may have impacted participants’ 
abilities to maintain these skills if they were actually being practiced (Lux, 2007).  Taken 
together, deficits in executive functioning, mood disorder and response effort may have 
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contributed to the high variability that was observed throughout the study and the failure 
for maintenance of CO reductions during the abstinence induction and baseline phases.     
     During times participants relapsed, they were provided with advice such as 
delaying their first cigarette of the day to afternoon hours, smoking only half of a 
cigarette or leaving the pack of cigarettes inside and staying away from other smokers.  It 
was also recommended that they review the power point packet that was given to them in 
their initial counseling session going over tips for quitting.  Amanda and Mark did 
mention smoking only half a cigarette.  Mark also mentioned that he usually smoked after 
eating breakfast and attempted to delay his cigarette to afternoon hours.  For Mark and 
Amanda, delaying their first cigarette may explain the reduction in variability in their 
second baseline.  The extent the advice was used and helped participants overall in 
reducing their smoking however is not known.  For Harry during the shaping phase it 
should be mentioned that it was discovered that he used the nicotine patch throughout the 
shaping phase which may explain the CO reductions at the start of the shaping phase. 
    Study samples were taken four times a day with the first sample taken between 
8 am and 9 am.  High variability was identified with all participants throughout all the 
conditions.  Early samples tended to be much lower than later samples mainly as a result 
of participants waking up.  As the day progressed, with CO having a half-life of 4-5 
hours, levels may have increased partly as a result of carry over effects.  However the 
number of cigarettes that are smoked across time versus the number of cigarettes smoked 
at one time may have different effects on CO level 4-5 hours later and should be 
examined more closely taking into account this possibility.    
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     Studies that have examined the use of vouchers took samples one to two times 
a day (Dallery & Glenn, 2005).  Other studies have taken samples three times a day.  
Participants in such cases would still have the opportunity to smoke abundantly in the 
early part of the day prior to their first sample and 5-6 hours later may be able to provide 
a sample that shows a reduction in CO levels.  To avoid this, sampling times originally 
were to be taken at 8 am, 1pm, 6 pm and 11 pm.  However, this changed to a somewhat 
random schedule once we tried to accommodate the changing program schedules.  This 
could possibly explain some of the variability.  With the semi-random nature of the 
sampling times one could argue that this may have prevented participants from “taking 
advantage” of the system.  For example if participants knew that a sample time was 
coming up they may be able to time their last cigarette so that their CO level was less 
than their previous reading.  Because the sampling times were somewhat unpredictable 
this may have reduced the likelihood of participants contacting the reinforcement 
contingency and contributed to the variability that was identified throughout the study.   
      Motivation was assessed using the University of Rhode Island Change 
Assessment Scale  (URICA) which assesses readiness to change along four stages pre-
contemplation, contemplation, action, and maintenance, and was developed by 
researchers without a behavior analytic background (Henderson, Saules, & Galen, 2004).  
Motivation may have been better addressed using a functional approach that identifies 
controlling variables to smoking.  Little research has been conducted that has 
incorporated the use of functional assessments for smoking.  Dallery, Glenn, and Raiff 
(2007) developed the University of Florida Functional Assessment Scale for Smoking 
(UFFAS) which is a 45 item questionnaire in which the participant rates the frequency of 
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reasons for smoking along a continuum from never to always and also rates the degree to 
which they agree with their response from strongly disagree to strongly agree.  The 
questionnaire provides questions that address controlling variables within a behavior 
analytic paradigm.  Understanding the controlling variables better could have provided 
much more individualized tips for quitting and may have been a more effective approach 
for individuals with TBI.  Cole and Bonem (2000) incorporated a functional assessment 
with two undergraduate students and developed individualized self-management 
strategies that led to significant reductions in exhaled CO levels with both participants.   
     The participants in the current study often times were unable to contact 
reinforcement because they did not provide a lower sample of CO.  In many cases 
participants were close to achieving their goal and achieving the abstinence criteria of 5 
ppm or less and thus never received reinforcement.  It was not until the abstinence criteria 
changed to 8 ppm that consistent reductions were observed for and Mark.  Giving a 
margin of freedom between 5 ppm and 8 ppm could have lead to reduced variability 
during the shaping and abstinence induction phases.  One additional thing to consider is 
that all participants had a history of substance abuse disorder.  Harry was the only 
participant currently attending AA meetings even though the option was still available for 
Mark and Amanda.  The extent of their nicotine dependency and history of drug use may 
be determining factors for the effectiveness of contingency management.   
     For participants that fail to contact the reinforcement contingency because of 
these factors percentile schedules may be more effective by increasing the likelihood of 
reinforcement for gradations of improvement.   Shaping procedures that have 
incorporated the use of percentile schedules in which vouchers are delivered contingent 
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on the participant providing a CO sample less than the last 3-7 lowest previous samples 
have shown positive outcomes.  Percentile schedules are designed so the participant will 
contact a minimum level of reinforcement for CO reductions.  This is a contrast from 
other studies which have provided vouchers for specific goals or having a reduction.  
Percentile schedules provide a CO window in which a participant will receive 
reinforcement.   Lamb, Morral, Kirby, Iguchi, and Galbicka (2004) used percentile 
schedules with hard to treat individuals in three conditions: 30th, 50th, and 70th 
percentile and found that greater reductions were observed with participants in the 70th 
percentile.   
     However, if contingency management is ineffective because the value of the 
money fails to compete with the reinforcing value of nicotine, a functional approach 
identifying controlling stimuli may be needed. Mark reportedly may not have needed the 
money because of his current income, but mentioned he still wanted to quit.  For either 
possibility, it is apparent that a more individualized plan that addresses the reinforcer 
differences of participants and allows for participants to contact the reinforcer 
contingency with minimal response effort is needed.  Future research should examine the 
use of percentile schedules as a shaping method and incorporate individualized 
reinforcers using a functional approach.  Research that incorporates the gathering of 
multiple samples a day should establish random times for taking samples to minimize the 
likelihood of participants circumventing the intervention.  Lastly, research should solicit 
the combined effort of all relevant staff members to ensure samples are not missed.     
Figure 1.  Multiple baseline design across 
shaping phase, relapses in the abstinence induction phase, and improvements for Harry 
and Mark during the standard pay phase.
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Figure 2: Craving scores as they are tracked across conditions
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Figure 3: Total withdrawal scores across phases with items 1-
9 summed on the MNWS. 
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  Precontemplation Contemplation Action Maintenance 
Amanda 11 33 25 26 
Harry 7 31 25 27 
Mark 17 31 32 27 
Note :  Scores from the URICA indicating readiness to change. 
* Continuous scores (C+A+M-PC) 
 
 
 
 
 
Note: Earnings across conditions and per participant 
 
 
 
 Shaping AB/IN Standard 
Pay 
Bonuses Total 
Mark $19.25 $0.00 $20.00 $50.00 $89.25 
Amanda $14.75 $14.00 $25.00 $50.00 $103.75 
Harry $25.00 $33.00 $45.00 $50.00 $153.00 
University of Rhode Island Change Assessment Scores 
Participant Earnings 
Table 1 
Table 2 
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Appendix A 
Instructions for Measuring CO Levels 
1) Press and hold the on/off button located on the side of the monitor until the 
display becomes active then release the button. 
2) Make sure to not cover the vents on the back of the device with your hand.   
3) Insert a D-piece into the instrument and fit a new cardboard mouth piece.   
4) Touch the icon of the person holding the monitor to begin the breath test. 
5) This begins the count down.  As the display counts down to zero, the participant 
should inhale their breath deeply until the count reaches zero.   
6) During the last 3 seconds, an audio beep will sound.   
7) When the count reaches zero, the participant should begin to exhale into the 
mouthpiece slowly, aiming to empty their lungs into the machine until the ppm 
rises and holds at the highest level. 
8) Remove and dispose of the cardboard mouth piece slowly. 
9) Remove the D-piece to allow fresh air to purge the sensor then place back. 
10)  Show and document the correct reading.   
 
 
 
 
 
 
 
 
 
 
 
 
